US2016039734A1PendingUtilityA1
Therapeutic curcumin derivatives
Est. expiryFeb 12, 2024(expired)· nominal 20-yr term from priority
Inventors:David L. Vander JagtLorraine M. DeckSteve F. AbcouwerRobert A. OrlandoRobert E. RoyerWaylon M. WeberEkaterina V. Bobrovnikova-MarjonLucy A. Hunsaker
A61K 31/121A61K 31/336C07C 49/255C07C 49/235A61K 31/704A61K 31/282A61K 45/06C07D 213/50G01N 2500/10G01N 33/5023A61K 31/337A61K 31/12G01N 33/5058A61K 31/137A61K 31/235A61K 31/444A61K 31/277
53
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Curcumin analogues and methods are provided for treatment of disease.
Claims
exact text as granted — not AI-modified1 . A method of treating a subject afflicted with Alzheimer's disease or type 2 diabetes, the method comprising administering to the subject a therapeutically effective amount of a composition comprising a curcumin derivative selected from the group consisting of:
(a) Ar 1 -L-Ar 2 (Formula I); wherein L is a divalent linking group comprising an alkylene or an alkenylene comprising 3, 4, 5, 6, or 7 backbone carbon atoms, wherein one or more of the backbone carbon atoms form part of a carbonyl or secondary alcohol; and Ar 1 and Ar 2 are each independently aryl groups; and (b) Ar 1 -L-R 11 (Formula IV); wherein L is a divalent linking group comprising an alkylene or an alkenylene comprising 3, 4, 5, 6, or 7 backbone carbon atoms, wherein one or more of the backbone carbon atoms form part of a carbonyl or secondary alcohol; Ar 1 is an aryl group; and R 11 is an alkyl group, a heterocyclic group, or a hydrogen.
2 .- 21 . (canceled)
22 . A method of treating a subject afflicted with cancer or a precancerous condition, the method comprising administering to the subject a therapeutically effective amount of a composition comprising a curcumin derivative selected from the group consisting of:
(a) Ar 1 -L-Ar 2 (Formula I); wherein L is a divalent linking group comprising an alkylene or an alkenylene comprising 3, 4, 5, 6, or 7 backbone carbon atoms, wherein one or more of the backbone carbon atoms form part of a carbonyl or secondary alcohol; and Ar 1 and Ar 2 are each independently aryl groups; and (b) Ar 1 -L-R 11 (Formula IV); wherein L is a divalent linking group comprising an alkylene or an alkenylene comprising 3, 4, 5, 6, or 7 backbone carbon atoms, wherein one or more of the backbone carbon atoms form part of a carbonyl or secondary alcohol; Ar 1 is an aryl group; and R 11 is an alkyl group, a heterocyclic group, or a hydrogen.
23 .- 28 . (canceled)
29 . A compound according to the chemical structure:
(a) Ar 1 -L-Ar 2 (Formula I); wherein L is a divalent linking group comprising an alkylene or an alkenylene comprising 3, 4, 5, 6, or 7 backbone carbon atoms, wherein one or more of the backbone carbon atoms form part of a carbonyl or secondary alcohol; and Ar 1 and Ar 2 are each independently aryl groups; or (b) Ar 1 -L-R 11 (Formula IV); wherein L is a divalent linking group comprising an alkylene or an alkenylene comprising 3, 4, 5, 6, or 7 backbone carbon atoms, wherein one or more of the backbone carbon atoms form part of a carbonyl or secondary alcohol; Ar 1 is an aryl group; and R 11 is an alkyl group, a heterocyclic group, or a hydrogen, or a pharmaceutically acceptable salt thereof.
30 . The compound of claim 29 , wherein either or both of Ar 1 and Ar 2 is independently a heteroaryl group.
31 . The compound of claim 29 , wherein the divalent linking group L is unsaturated.
32 . The compound of claim 29 , wherein L is an alkylene or an alkenylene selected from the group consisting of:
—CH═CH—CHO—,
—CH═CH—(CO)—CH═CH—,
—CH 2 —CH 2 —(CO)—CH 2 —CH 2 —,
—CH 2 —CH 2 —CH(OH)—CH 2 —CH 2 —,
—CH═CH—(CO)—CR═C(OH)—CH═CH—,
—CH═CH—(CO)—CR 2 —(CO)—CH═CH—, and
—CH═CH—(CO)—CH—C(OH)—CH═CH—;
wherein R consists of an alkyl or aryl group comprising 10 carbon atoms or less.
33 . The compound of claim 29 , wherein at Ar 1 is a phenyl group according to Formula II:
and each of R 1 -R 5 is independently selected from the group consisting of hydroxyl, methyl, methoxyl, dimethylamine, trifluoromethyl, chloro, fluoro, acetoxyl, cyano, and carboxymethyl.
34 . The compound of claim 33 , wherein Ar 2 is a phenyl group according to Formula III:
and each of R 6 -R 10 is independently selected from the group consisting of hydroxyl, methyl; methoxyl, dimethylamine, trifluoromethyl, chloro, fluoro, acetoxyl, cyano, and carboxymethyl.Join the waitlist — get patent alerts
Track US2016039734A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.